Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA treatment in Addison's disease
2009-018209-32Phase 3Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Feb 2010
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dehydroepiandrosterone in Addison's disease (2 arms), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Primary endpoint: clinical parameters, Primary endpoint: metabolic parameters and 1 more. Started Feb 2010; status: active.
02
Drugs
dehydroepiandrosterone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on 2009-018209-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018209-32.